Corneal Allograft Rejection and Failure

Corneal allograft rejection is an immunologic response in which the recipient’s immune system specifically attacks donor corneal tissue, leading to inflammation, edema, and potential graft failure. Unlike nonimmune causes of graft failure, rejection involves host T‑cells and antibodies recognizing foreign antigens on donor cells Medscape. Corneal allograft failure, by contrast, denotes irreversible loss of graft clarity and function, whether due to immunologic rejection or non‑immune factors such as primary endothelial insufficiency, infection, or mechanical injury. Primary donor graft failure occurs when persistent edema never clears in the early postoperative period due to donor endothelial cell deficiencies, surgical trauma, or prolonged storage EyeWiki.

Corneal allograft rejection occurs when the recipient’s immune system recognizes donor corneal tissue as foreign and mounts an immune response against it. This process involves activation of host T cells and antibodies that damage donor endothelial cells, leading to loss of corneal clarity and vision disturbance Medscape. Clinically, rejection episodes can manifest as redness, pain, light sensitivity, and decreased vision, and without prompt treatment may progress to irreversible graft failure NCBI.

Graft failure refers to any irreversible loss of graft transparency or function after transplantation. Primary graft failure is evident when a donor cornea never clears postoperatively—often due to donor tissue quality or surgical trauma—and is distinguished from later failure caused by rejection or other complications EyeWikiScienceDirect. Secondary graft failure can occur months to years later due to immunologic rejection, endothelial decompensation, elevated intraocular pressure, or recurrence of original disease PubMed.


Types

1. Tissue‑Layer Classification

  • Epithelial rejection: Rare; involves only the outermost layer and often self‑limited.

  • Subepithelial (stromal) rejection: Presents as focal subepithelial infiltrates beneath Bowman’s layer.

  • Endothelial rejection: Most common; characterized by a Khodadoust line of inflammatory cells migrating over the endothelium.

  • Mixed rejection: Features of both epithelial and endothelial involvement EyeWiki.

2. Temporal Classification

  • Hyperacute (<24 hours): Driven by preformed antibodies causing complement activation and rapid graft necrosis.

  • Acute (days–weeks): Mediated by host T‑cells recognizing donor MHC (HLA) antigens, leading to endothelial cell damage.

  • Chronic (months–years): Insidious vascular and fibrotic changes causing gradual loss of graft clarity Wikipedia.

3. Failure Classification

  • Primary graft failure: Early, irreversible edema due to donor endothelial cell loss, surgical trauma, or storage injury.

  • Immunologic failure: Progressive decompensation after unresolved rejection episodes.

  • Non‑immune failure: Includes endothelial decompensation without rejection, elevated IOP/glaucoma, ocular surface disease, recurrence of primary pathology, wound dehiscence, or trauma.

  • Lamellar‑specific failure: Unique to partial‑thickness techniques (e.g., DALK, DSAEK) PubMed.


Causes

  1. Preoperative Ocular Surface Inflammation
    Active keratitis or conjunctivitis disrupts immune privilege and raises rejection risk EyeWiki.

  2. Corneal Neovascularization
    New blood vessels (>2 quadrants) permit immune cells access to the graft, increasing antigen exposure EyeWiki.

  3. Young Recipient Age
    More robust immune response in younger patients accelerates rejection rates EyeWiki.

  4. History of Graft Rejection
    Prior rejection episodes predispose to repeat immune attacks and failure EyeWiki.

  5. Large Graft Diameter
    Bigger grafts carry more donor antigen and a larger wound surface, heightening immune stimulation EyeWiki.

  6. Loose or Broken Sutures
    Chronic irritation and microleaks trigger inflammation and neovascularization EyeWiki.

  7. Prior Ocular Surgery
    Surgery‑induced inflammation and scarring amplify immune surveillance EyeWiki.

  8. Glaucoma Medications or Surgery
    Reduced ocular surface health and steroid dependency can precipitate rejection EyeWiki.

  9. HLA Mismatch (Tissue Incompatibility)
    Differences in donor and recipient HLA antigens promote T‑cell allorecognition and rejection Wikipedia.

  10. Donor‑Specific Antibodies
    Preformed or de novo anti‑HLA antibodies mediate humoral rejection and endothelial injury Wikipedia.

  11. Low Donor Endothelial Cell Density
    <2000 cells/mm² impairs deturgescence, risking primary failure EyeWiki.

  12. Prolonged Donor Tissue Storage
    Storage >7 days increases cell death and primary graft edema EyeWiki.

  13. Surgical Trauma to Endothelium
    Physical injury during trephination or suturing can irreversibly damage endothelial cells EyeWiki.

  14. Infection (Bacterial/Viral/Fungal)
    Post‑transplant keratitis and endophthalmitis lead to inflammatory failure Wikipedia.

  15. Recurrence of Primary Disease
    Herpes simplex, keratolysis, or autoimmune colitis re‑damages grafted tissue PubMed.


Symptoms

  1. Loss of Vision
    Patients often note a sudden or gradual decrease in clarity as graft edema develops Mayo Clinic.

  2. Blurred Vision
    Fluctuating focal irregularities and stromal haze degrade visual acuity PMC.

  3. Eye Pain or Ache
    Inflammatory insult and raised IOP can cause aching discomfort Mayo Clinic.

  4. Red Eyes
    Conjunctival injection reflects anterior segment inflammation and neovascularization Mayo Clinic.

  5. Photophobia
    Light sensitivity arises from epithelial disruption and anterior chamber cells Mayo Clinic.

  6. Ocular Irritation
    Patients describe a persistent gritty or scratchy sensation Review of Optometry.

  7. Excessive Tearing (Epiphora)
    Reflex tearing due to surface irritation and corneal edema Review of Optometry.

  8. Vision Fluctuations
    Day‑to‑day changes in clarity as immune activity waxes and wanes LinkedIn.

  9. Halos or Glare Around Lights
    Stromal edema alters light refraction, producing halos .

  10. Foreign‑Body Sensation
    Endothelial folds and surface irregularity feel like grit under the eyelid Dove Medical Press.


Diagnostic Tests

Physical Exam 

  1. Visual Acuity Testing
    Standard Snellen or near‑vision charts quantify loss of function Wikipedia.

  2. Slit‑Lamp Biomicroscopy
    High‑magnification assessment reveals graft edema, Descemet folds, and keratic precipitates EyeWiki.

  3. Intraocular Pressure Measurement (Tonometry)
    Goldmann or non‑contact tonometry detects elevated IOP contributing to endothelial stress NCBI.

  4. Corneal Sensitivity Testing (Esthesiometry)
    Qualitative (cotton‑wisp) or quantitative (Cochet‑Bonnet aesthesiometer) methods assess trigeminal nerve integrity EyeWiki.

Manual Tests 

  1. Seidel Test
    Fluorescein dye under cobalt blue light reveals aqueous leaks at suture sites or microperforations Wikipedia.

  2. Fluorescein Staining
    Highlights epithelial defects and areas of micro‑erosion in the graft surface Wikipedia.

  3. Rose Bengal or Lissamine Green Staining
    Detects devitalized epithelial cells and mucin‑deficient areas mostafavieye.com.

  4. Schirmer Test
    Quantifies tear production to evaluate ocular surface health predisposing to failure mostafavieye.com.

Lab & Pathological Tests 

  1. Aqueous Humor PCR
    Polymerase chain reaction for herpes simplex, CMV, or other pathogens in suspected viral endotheliitis EyeWiki.

  2. Aqueous Humor Cytology
    Cell counts and differential to detect inflammatory cell infiltrate Medscape.

  3. Donor‑Specific Antibody ELISA
    Quantifies anti‑HLA antibodies in serum to confirm humoral rejection mechanisms Medscape.

  4. Corneal Button Histopathology
    Examines excised graft tissue post‑regraft for immune cell infiltration and stromal necrosis PubMed.

Electrodiagnostic Tests 

  1. Corneal Endothelial Potential Measurement
    Experimental assessment of transendothelial electrical potential as a marker of cell function MDPI.

  2. Somatosensory Evoked Potentials (Blink Reflex)
    Evaluates trigeminal nerve conduction altered in neurotrophic graft failure Wikipedia.

  3. Electrooculography (EOG)
    Assesses RPE and corneal potential changes secondary to widespread ocular inflammation Wikipedia.

  4. Corneal Nerve Electrophysiology
    Nerve conduction studies of corneal afferents in chronic graft failure research PMC.

Imaging Tests

  1. Specular Microscopy
    Noninvasive imaging of endothelial cell density, pleomorphism, and polymegethism Medscape.

  2. In Vivo Confocal Microscopy
    High‑resolution visualization of sub‑basal nerve plexus and immune cells Medscape.

  3. Anterior Segment Optical Coherence Tomography (AS‑OCT)
    Cross‑sectional mapping of corneal thickness and stromal edema extent Medscape.

  4. Corneal Topography
    Evaluates surface regularity and astigmatism changes from stromal scarring Wikipedia.

Non‑Pharmacological Treatments

Exercise Therapies

  1. Aerobic Exercise
    Description: Moderate‑intensity aerobic activities such as brisk walking or cycling for at least 150 minutes per week.
    Purpose: Lowers systemic inflammation to support graft survival.
    Mechanism: Regular aerobic training decreases C‑reactive protein (CRP) and interleukin‑6 (IL‑6), reducing pro‑inflammatory signaling that can exacerbate immune responses against the graft PMCMDPI.

  2. Resistance Training
    Description: Supervised weight or resistance band exercises 2–3 times per week.
    Purpose: Improves muscle strength and metabolic health to modulate immunity.
    Mechanism: Resistance training has been shown to reduce tumor necrosis factor‑alpha (TNF‑α) and other cytokines, improving the immunologic environment for graft acceptance PMCFrontiers.

  3. Combined Aerobic + Resistance
    Description: A program blending cardio and strength sessions across the week.
    Purpose: Achieves synergistic anti‑inflammatory effects.
    Mechanism: Combined training protocols produce greater reductions in CRP and TNF‑α than either modality alone, offering dual protection against immune‑mediated graft damage PMCLippincott Journals.

  4. Yoga
    Description: Twice‑weekly classes focusing on postures (asanas), breathing (pranayama), and relaxation.
    Purpose: Reduces psychological stress that can heighten immune reactivity.
    Mechanism: Yoga down‑regulates the hypothalamic‑pituitary‑adrenal axis, leading to decreased cortisol release and attenuation of inflammatory mediators ScienceDirectuclastresslab.org.

  5. Tai Chi
    Description: Low‑impact martial art emphasizing slow, flowing movements.
    Purpose: Enhances balance and reduces physiologic stress.
    Mechanism: Studies link Tai Chi practice to lower IL‑6 and CRP levels, supporting immune tolerance of transplanted tissue ScienceDirectPNAS.

  6. Blinking & Eye Movement Exercises
    Description: Daily regiment of deliberate blinking and gentle eye‑tracking motions.
    Purpose: Maintains tear film homeostasis and ocular surface health.
    Mechanism: Proper blinking distributes tears, reduces surface friction and inflammation, and preserves epithelial integrity over the graft MedlinePlusOphthalmic Consultants of Vermont.

  7. Warm Compress & Lid Massage
    Description: Twice‑daily application of warm compresses with gentle eyelid massage.
    Purpose: Improves meibomian gland function and ocular surface lubrication.
    Mechanism: Heat and massage unclog glands, stabilize tear film, and reduce ocular surface inflammation that can endanger graft health AAO Journal.

Mind‑Body Therapies

  1. Mindfulness Meditation
    Description: 10–20 minutes daily of seated awareness practice.
    Purpose: Mitigates stress‑induced immune activation.
    Mechanism: Meditation reduces NF‑κB activity, CRP, and IL‑6, promoting an anti‑inflammatory profile supportive of graft survival ScienceDirectimmusehealth.com.

  2. Guided Imagery
    Description: Audio‑led visualization sessions focused on healing imagery.
    Purpose: Enhances relaxation and coping with postoperative recovery.
    Mechanism: Imagery techniques lower stress hormones and cytokine release, improving immunologic tolerance LIDSEN PublishingHealth.

  3. Progressive Muscle Relaxation
    Description: Systematic tensing and releasing of muscle groups over 10–15 minutes.
    Purpose: Reduces overall sympathetic arousal.
    Mechanism: By lowering sympathetic output, this technique diminishes inflammatory mediator release that could trigger rejection ScienceDirect.

  4. Biofeedback
    Description: Instructor‑led sessions using sensors to monitor physiological responses.
    Purpose: Teaches control over blood pressure and stress.
    Mechanism: Enhanced autonomic regulation through biofeedback reduces stress‑related inflammation ScienceDirect.

  5. Yoga‑Based Mindfulness
    Description: Fusion of gentle yoga and mindful breathing.
    Purpose: Integrates physical and mental relaxation.
    Mechanism: Combined practice yields additive decreases in cytokines compared to yoga alone ScienceDirectMDPI.

  6. Stress Management Counseling
    Description: Cognitive‑behavioral strategies taught by a psychologist.
    Purpose: Addresses anxiety and improves adherence to care.
    Mechanism: CBT reduces chronic stress responses, lowering cortisol and inflammatory cycles LIDSEN Publishing.

  7. Qigong
    Description: Gentle movement, breath control, and mental focus exercises.
    Purpose: Promotes energy flow and stress reduction.
    Mechanism: Research shows Qigong practitioners have reduced inflammatory markers and improved immune cell function ScienceDirectLIDSEN Publishing.

Educational Self‑Management

  1. Ocular Hygiene Education
    Description: Training in lid cleaning and lash care to prevent infection.
    Purpose: Minimizes microbial load on graft surface.
    Mechanism: Regular eyelid hygiene reduces blepharitis and surface inflammation MedlinePlus.

  2. Postoperative Care Workshops
    Description: Group or one‑on‑one sessions covering drop schedules and activity restrictions.
    Purpose: Ensures correct technique and adherence.
    Mechanism: Structured education improves compliance, reducing risk of early rejection Mayo Clinic.

  3. Symptom Monitoring Logs
    Description: Daily diary of vision changes, redness, or discomfort.
    Purpose: Facilitates early detection of rejection signs.
    Mechanism: Prompt recognition leads to faster treatment and improved graft outcomes MedlinePlus.

  4. Telehealth Follow‑Ups
    Description: Scheduled video visits to review healing and medication use.
    Purpose: Provides timely support and intervention.
    Mechanism: Remote monitoring increases follow‑up adherence and early management of complications OAText.

  5. Support Group Participation
    Description: Peer meetings for sharing experiences and coping strategies.
    Purpose: Enhances emotional well‑being and self‑efficacy.
    Mechanism: Social support reduces stress, indirectly benefitting immune regulation OAText.

  6. Digital Self‑Care Apps
    Description: Mobile applications for medication reminders and educational modules.
    Purpose: Automates adherence and tracking of care instructions.
    Mechanism: Digital prompts improve drop regimen compliance, reducing rejection risk OAText.


Essential Pharmacological Agents

  1. Prednisolone Acetate 1% (Topical)
    Used hourly while awake for endothelial rejection, then tapered over weeks; class: corticosteroid; side effects: elevated intraocular pressure, cataract formation MedscapeMedscape.

  2. Dexamethasone 0.1% (Topical)
    Prescribed 4–6 times daily initially for stromal/epithelial rejection; class: corticosteroid; side effects: ocular hypertension, delayed wound healing Medscape.

  3. Difluprednate 0.05% (Topical, Durezol)
    1–2 drops every 6 hours for severe rejection; class: fluorinated corticosteroid; side effects: higher risk of steroid‑induced glaucoma Medscape.

  4. Cyclosporine 0.05% (Topical)
    Four times daily as adjunct immunosuppression; class: calcineurin inhibitor; side effects: ocular burning, less effective than steroids alone PubMed.

  5. Tacrolimus 0.03% (Topical)
    Twice daily in high‑risk patients; class: calcineurin inhibitor; side effects: transient ocular irritation EyeWiki.

  6. Oral Prednisone
    1 mg/kg/day for 1 week then taper; class: systemic corticosteroid; side effects: systemic immunosuppression, hyperglycemia, osteoporosis Wikipedia.

  7. Mycophenolate Mofetil
    1 g twice daily; class: antimetabolite; side effects: gastrointestinal upset, leukopenia Wikipedia.

  8. Azathioprine
    1–2 mg/kg/day; class: antimetabolite; side effects: bone marrow suppression, hepatotoxicity Wikipedia.

  9. Tacrolimus (Systemic)
    2–12 mg/day in divided doses; class: calcineurin inhibitor; side effects: nephrotoxicity, neurotoxicity EyeWiki.

  10. Sirolimus
    2 mg/day; class: mTOR inhibitor; side effects: hyperlipidemia, delayed wound healing Wikipedia.


 Dietary Molecular Supplements

  1. Omega‑3 Fatty Acids (1,000–3,000 mg/day)
    Anti‑inflammatory effects via eicosanoid modulation; reduces IL‑6 and CRP MDPIReal Simple.

  2. Curcumin (500 mg–2 g/day)
    Inhibits NF‑κB activation and pro‑inflammatory cytokines (TNF‑α, IL‑1β, IL‑6) MDPI.

  3. Vitamin D (2,000 IU/day)
    Immunomodulatory; promotes regulatory T‑cell function and reduces graft‑targeted inflammation Wikipedia.

  4. Vitamin C (500 mg twice daily)
    Antioxidant; scavenges free radicals to protect endothelial cells PMC.

  5. Zinc (15–30 mg/day)
    Cofactor for antioxidant enzymes; enhances wound healing Wikipedia.

  6. N‑Acetylcysteine (600 mg twice daily)
    Precursor to glutathione; reduces oxidative stress Wikipedia.

  7. Coenzyme Q10 (100 mg/day)
    Mitochondrial antioxidant; preserves endothelial cell function Wikipedia.

  8. Lutein + Zeaxanthin (10 mg/2 mg daily)
    Ocular antioxidants protecting corneal cells PMC.

  9. Resveratrol (100 mg/day)
    Inhibits inflammatory mediators via SIRT1 activation Wikipedia.

  10. Green Tea Polyphenols (500 mg EGCG/day)
    Antioxidant and anti‑inflammatory; modulates immune cell signaling Wikipedia.


Regenerative and Stem Cell Therapies

  1. Holoclar® (Limbal Stem Cell Therapy)
    Ex vivo autologous limbal epithelial cell sheet replacing damaged limbus; dose: single surgical implantation; mechanism: restores epithelial renewal capacity Wikipedia.

  2. Mesenchymal Stem Cell Eye Drops
    Pilot studies use 1–2 × 10^6 cells/drop weekly; mechanism: MSCs secrete anti‑inflammatory cytokines and growth factors Wikipedia.

  3. Bone Marrow‑Derived Stem Cells
    Intrastromal injection of 1 × 10^6 cells; functions via paracrine immunomodulation Wikipedia.

  4. Amniotic Membrane Transplantation
    Cryopreserved amniotic graft applied weekly; benefits from stem cell–rich membrane cytokines that promote healing Aetna.

  5. Exosomes from MSCs
    Topical instillation of purified exosomes 3 times/week; mechanism: transfer of miRNAs that suppress rejection pathways Wikipedia.

  6. Bioengineered Corneal Constructs
    Biosynthetic collagen‐based implants seeded with stem cells; mechanism: supports host cell repopulation and immune tolerance Wikipedia.


Surgical Interventions

  1. Repeat Penetrating Keratoplasty (PKP)
    Full‑thickness donor button exchange; benefits: restores vision in failed grafts; requires intensive immunosuppression Verywell Health.

  2. Deep Anterior Lamellar Keratoplasty (DALK)
    Selective replacement of anterior stroma preserving host endothelium; benefits: lower rejection risk Verywell Health.

  3. Endothelial Keratoplasty (DSAEK/DMEK)
    Transplantation of only the endothelial cell layer; benefits: faster recovery, less astigmatism Verywell Health.

  4. Amniotic Membrane Grafting
    Patch of amniotic tissue over graft; benefits: anti‑inflammatory, promotes epithelialization Aetna.

  5. Temporary Tarsorrhaphy
    Partial eyelid closure to protect the cornea; benefits: shields against exposure and promotes healing EyeWiki.


Prevention Strategies

  1. HLA‑Matching When Possible
    Reduces immunologic mismatch and rejection risk PMC.

  2. Use of Low‑Risk Donor Tissue
    Pre‑select corneas with ≥2,000 endothelial cells/mm² and <7 days storage EyeWiki.

  3. Perioperative Topical Steroids
    Aggressive steroid prophylaxis during and after surgery Medscape.

  4. Control of Preexisting Inflammation
    Treat ocular surface disease before transplant PMC.

  5. Infection Screening of Donor Tissue
    Rigorous serological testing to prevent infection‐induced rejection Wikipedia.

  6. Avoidance of Ocular Surface Trauma
    Protective eyewear and activity restrictions Verywell Health.

  7. Long‑Term Low‑Dose Steroid Maintenance
    Continued steroid taper over months to years Medscape.

  8. Regular Follow‑Up Visits
    Early detection of signs via slit‑lamp exam AAO.

  9. Patient Education on Drop Regimens
    Ensures adherence and correct application MedlinePlus.

  10. Management of Glaucoma and IOP
    Monitor and treat elevated intraocular pressure promptly AAO Journal.


When to See a Doctor

Seek immediate ophthalmic evaluation if you experience new redness, pain, light sensitivity, or a sudden decrease in vision at any time after transplant. Early intervention within 24 hours of symptom onset can often reverse rejection episodes and preserve graft clarity AAO.


What to Do and What to Avoid

  1. Do use prescribed eye drops exactly as directed MedlinePlus.

  2. Don’t rub or press on the transplanted eye Verywell Health.

  3. Do wear protective eyewear during activities that risk trauma Verywell Health.

  4. Don’t expose the eye to water from pools or hot tubs Verywell Health.

  5. Do maintain lid hygiene and eye cleanliness MedlinePlus.

  6. Don’t skip follow‑up visits or delay reporting symptoms Mayo Clinic.

  7. Do attend educational self‑management sessions OAText.

  8. Don’t abruptly stop medications without consulting your doctor MedlinePlus.

  9. Do practice stress‑reducing exercises like yoga or meditation ScienceDirect.

  10. Don’t smoke or use tobacco products, as they impair healing Real Simple.


Frequently Asked Questions

  1. What are the first signs of graft rejection?
    Early signs include redness, sensitivity to light, pain, and decreased vision NCBI.

  2. How is rejection diagnosed?
    Diagnosis is by slit‑lamp exam revealing keratic precipitates, Khodadoust line, and stromal edema AAO.

  3. Can rejection be reversed?
    Yes—if treated promptly with intensive topical steroids, most rejection episodes are reversible Medscape.

  4. How long will my corneal graft last?
    Many grafts last 10–15 years or longer; regular follow‑up and adherence improve longevity Verywell Health.

  5. Is re‑transplantation possible after failure?
    Yes—repeat keratoplasty often restores vision but may have higher rejection risk Verywell Health.

  6. Are there alternatives to donor corneas?
    Bioengineered corneas and amniotic membrane approaches are investigational alternatives Wikipedia.

  7. How should I store and apply eye drops?
    Store as directed (some refrigerated), wash hands before instilling, and wait 5 minutes between different drops Ophthalmic Consultants of Vermont.

  8. Can I travel after transplant?
    Yes, with adequate supply of medications and protective eyewear; avoid dusty or windy environments AAO.

  9. Does exercise harm my graft?
    Moderate exercise supports healing; avoid contact sports or heavy lifting that raise eye pressure Verywell Health.

  10. What infections should I watch for?
    Report any discharge, increasing redness, or pain—these may indicate bacterial or fungal infection MedlinePlus.

  11. Will I need glasses after graft?
    Yes—astigmatism or refractive error often persists and can be corrected with glasses or contacts Verywell Health.

  12. Can I wear makeup or contact lenses?
    Wait until your surgeon approves—usually months post‑surgery; maintain strict hygiene MedlinePlus.

  13. Are dietary supplements safe?
    When used as directed, supplements like omega‑3 and curcumin are generally safe; discuss with your doctor MDPI.

  14. What if I miss a dose of drops?
    Instill as soon as you remember, then resume schedule; do not double‑dose Ophthalmic Consultants of Vermont.

  15. How often should I have eye exams?
    Initially, weekly or biweekly; once stable, every 3–6 months or as recommended AAO.

Disclaimer: Each person’s journey is unique, treatment planlife stylefood habithormonal conditionimmune systemchronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 21, 2025.

 

      RxHarun
      Logo
      Register New Account